• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人认知障碍及治疗策略。

Cognitive Impairment in Older Adults and Therapeutic Strategies.

机构信息

Department of Pathology, Stanford University, Stanford, California (T.J.M., S.A.B.) and Pacific Health Research and Education Institute, Honolulu, Hawaii (L.R.W.)

Department of Pathology, Stanford University, Stanford, California (T.J.M., S.A.B.) and Pacific Health Research and Education Institute, Honolulu, Hawaii (L.R.W.).

出版信息

Pharmacol Rev. 2021 Jan;73(1):152-162. doi: 10.1124/pharmrev.120.000031.

DOI:10.1124/pharmrev.120.000031
PMID:33298513
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7736830/
Abstract

Cognitive impairment and its severe form dementia are increasingly prevalent in older adults and loom as a public health disaster unless effective interventions are developed. Cognitive impairment is a convergent trait caused by damage from an idiosyncratic mix of four prevalent diseases (Alzheimer disease; vascular brain injury; Lewy body diseases, such as Parkinson disease and dementia with Lewy bodies; and limbic-predominant age-related transactive response DNA-binding protein 43 encephalopathy) that is counterbalanced by individually varying resilience, which is comprised of reserve and compensation. Brain regional damage from each of these four prevalent diseases is generated by the net effect of injury and (mal)adaptive response and is accompanied by characteristic lesions. Existing therapeutics enhance resilience, whereas most agents under development target mechanisms of damage with only suppression of vascular brain injury yet to show therapeutic promise. We hope to anticipate future tailored interventions that target mechanisms of damage and thereby avert the oncoming surge of cognitive impairment and dementia in older adults. SIGNIFICANCE STATEMENT: Brain regional damage is generated by the net effect of injury and (mal)adaptive response. The extent to which signs and symptoms of such damage occur is influenced by an underlying resilience comprising reserve and compensation. Finding tailored interventions that target specific mechanisms of damage likely yields the most effective therapies.

摘要

认知障碍及其严重形式痴呆在老年人中越来越普遍,如果不开发出有效的干预措施,将会成为一场公共卫生灾难。认知障碍是一种趋同特征,由四种常见疾病(阿尔茨海默病;血管性脑损伤;路易体疾病,如帕金森病和路易体痴呆;和边缘为主的与年龄相关的转录反应 DNA 结合蛋白 43 脑病)的独特混合造成的损伤引起,这种损伤被个体差异的适应能力所平衡,适应能力包括储备和代偿。这四种常见疾病中的每一种对大脑区域的损害都是由损伤和(适应性)反应的净效应产生的,同时伴有特征性病变。现有的治疗方法增强了适应能力,而大多数正在开发的药物都针对损伤机制,只有血管性脑损伤的抑制作用显示出治疗前景。我们希望预测未来针对损伤机制的定制干预措施,从而避免老年人认知障碍和痴呆的即将到来的激增。

意义陈述

大脑区域的损伤是由损伤和(适应性)反应的净效应产生的。这种损伤的迹象和症状的发生程度受到储备和代偿组成的内在适应能力的影响。寻找针对特定损伤机制的定制干预措施可能会产生最有效的治疗方法。

相似文献

1
Cognitive Impairment in Older Adults and Therapeutic Strategies.老年人认知障碍及治疗策略。
Pharmacol Rev. 2021 Jan;73(1):152-162. doi: 10.1124/pharmrev.120.000031.
2
Neuropathology of Dementia Disorders.痴呆障碍的神经病理学。
Continuum (Minneap Minn). 2022 Jun 1;28(3):834-851. doi: 10.1212/CON.0000000000001137.
3
Significance of brain lesions in Parkinson disease dementia and Lewy body dementia.帕金森病痴呆和路易体痴呆中脑损伤的意义。
Front Neurol Neurosci. 2009;24:114-125. doi: 10.1159/000197890. Epub 2009 Jan 26.
4
Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.路易体痴呆与帕金森病痴呆:当前的概念和争议。
J Neural Transm (Vienna). 2018 Apr;125(4):615-650. doi: 10.1007/s00702-017-1821-9. Epub 2017 Dec 8.
5
Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.老年社区居住的路易体患者认知障碍、衰退和波动。
Brain. 2012 Oct;135(Pt 10):3005-14. doi: 10.1093/brain/aws234.
6
Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.路易体痴呆的轻度认知障碍:更新与展望。
J Neural Transm (Vienna). 2023 Dec;130(12):1491-1508. doi: 10.1007/s00702-023-02670-1. Epub 2023 Jul 7.
7
Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.帕金森病痴呆患者MRI上的颞叶萎缩:与阿尔茨海默病和路易体痴呆的比较
Neurology. 2005 Mar 8;64(5):861-5. doi: 10.1212/01.WNL.0000153070.82309.D4.
8
The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons.路易体与以边缘系统为主的与年龄相关的 TDP-43 蛋白病神经病理改变的关联及其在老年人认知和阿尔茨海默病中的作用。
Acta Neuropathol Commun. 2021 Sep 25;9(1):156. doi: 10.1186/s40478-021-01260-0.
9
Dementia with Lewy bodies: neuropathology.路易体痴呆:神经病理学
J Geriatr Psychiatry Neurol. 2002 Winter;15(4):210-6. doi: 10.1177/089198870201500406.
10
Neuropathological findings in multiple system atrophy with cognitive impairment.认知障碍性多系统萎缩的神经病理学发现。
J Neural Transm (Vienna). 2020 Jul;127(7):1031-1039. doi: 10.1007/s00702-020-02201-2. Epub 2020 May 4.

引用本文的文献

1
Combined effect of cognitive dysfunction and sleep disturbance on mortality risk: NHANES 2011-2014.认知功能障碍与睡眠障碍对死亡风险的联合影响:2011 - 2014年美国国家健康与营养检查调查(NHANES)
Ann Gen Psychiatry. 2025 Sep 2;24(1):52. doi: 10.1186/s12991-025-00593-7.
2
Deep learning-based cell type profiles reveal signatures of Alzheimer's disease resilience and resistance.基于深度学习的细胞类型图谱揭示了阿尔茨海默病恢复力和抵抗力的特征。
Brain. 2025 Aug 5. doi: 10.1093/brain/awaf285.
3
Exploring the pharmacological mechanisms and therapeutic implications of galangin against neurological disorders.探索高良姜素抗神经疾病的药理机制及治疗意义。
Pharmacol Rep. 2025 Jun 20. doi: 10.1007/s43440-025-00756-z.
4
Development and multi-center validation of a high-performance predictive model for early detection of cognitive impairment in older adults: data-based on communities in Northern China.老年人认知障碍早期检测高性能预测模型的开发与多中心验证:基于中国北方社区的数据
Neurol Sci. 2025 Jun 14. doi: 10.1007/s10072-025-08293-6.
5
Physical activity and cognitive function among community-dwelling older adults: a mediating role of functional fitness.社区居住老年人的身体活动与认知功能:功能性体适能的中介作用
BMC Public Health. 2025 Mar 21;25(1):1081. doi: 10.1186/s12889-025-22321-2.
6
The relationship between estimated glucose disposal rate and cognitive function in older individuals.老年人中估计的葡萄糖处置率与认知功能之间的关系。
Sci Rep. 2025 Feb 18;15(1):5874. doi: 10.1038/s41598-025-89623-8.
7
The association between preserved ratio impaired spirometry (PRISm) and cognitive function among American older adults: the mediating role of systolic blood pressure.美国老年人中比值保留型气流受限(PRISm)与认知功能的关系:收缩压的中介作用。
BMC Geriatr. 2024 Oct 24;24(1):870. doi: 10.1186/s12877-024-05349-8.
8
Relationship between residual cholesterol and cognitive performance: a study based on NHANES.残余胆固醇与认知表现之间的关系:一项基于美国国家健康与营养检查调查(NHANES)的研究
Front Nutr. 2024 Sep 11;11:1458970. doi: 10.3389/fnut.2024.1458970. eCollection 2024.
9
The Role of Physical Activity in Adjunctive Nursing Management of Neuro-Degenerative Diseases among Older Adults: A Systematic Review of Interventional Studies.体育活动在老年人神经退行性疾病辅助护理管理中的作用:干预性研究的系统评价
Life (Basel). 2024 May 7;14(5):597. doi: 10.3390/life14050597.
10
Binary Nano-inhalant Formulation of Icariin Enhances Cognitive Function in Vascular Dementia via BDNF/TrkB Signaling and Anti-inflammatory Effects.淫羊藿苷二元纳米吸入制剂通过 BDNF/TrkB 信号通路和抗炎作用增强血管性痴呆的认知功能。
Neurochem Res. 2024 Jul;49(7):1720-1734. doi: 10.1007/s11064-024-04129-5. Epub 2024 Mar 23.

本文引用的文献

1
Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval.阿杜卡奴单抗、根特纳单抗、BAN2401 和 ALZ-801——用于治疗阿尔茨海默病的首批靶向淀粉样蛋白药物,具有近期获批的潜力。
Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.
2
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.阿尔茨海默病患者血浆 P-tau181:与其他生物标志物的关系、鉴别诊断、神经病理学和向阿尔茨海默病痴呆的纵向进展。
Nat Med. 2020 Mar;26(3):379-386. doi: 10.1038/s41591-020-0755-1. Epub 2020 Mar 2.
3
Amyloid-β and Tau at the Crossroads of Alzheimer's Disease.淀粉样β蛋白和 Tau 蛋白在阿尔茨海默病中的交汇点。
Adv Exp Med Biol. 2019;1184:187-203. doi: 10.1007/978-981-32-9358-8_16.
4
genotype regulates pathology and disease progression in synucleinopathy.基因型调节突触核蛋白病中的病理变化和疾病进展。
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aay3069.
5
APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid.载脂蛋白E4(APOE4)会加剧α-突触核蛋白病变及相关毒性,且与淀粉样蛋白无关。
Sci Transl Med. 2020 Feb 5;12(529). doi: 10.1126/scitranslmed.aay1809.
6
Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study.在一项 5000 人的神经病理学研究中,APOE2 纯合子患阿尔茨海默病痴呆的可能性极低。
Nat Commun. 2020 Feb 3;11(1):667. doi: 10.1038/s41467-019-14279-8.
7
Precision medicine in Parkinson's disease: emerging treatments for genetic Parkinson's disease.精准医学在帕金森病中的应用:针对遗传性帕金森病的新兴治疗方法。
J Neurol. 2020 Mar;267(3):860-869. doi: 10.1007/s00415-020-09705-7. Epub 2020 Jan 23.
8
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.载脂蛋白 E3 基督城纯合子对常染色体显性阿尔茨海默病的抗性:一例报告。
Nat Med. 2019 Nov;25(11):1680-1683. doi: 10.1038/s41591-019-0611-3. Epub 2019 Nov 4.
9
Diagnosis and Management of Dementia: Review.痴呆的诊断与管理:综述。
JAMA. 2019 Oct 22;322(16):1589-1599. doi: 10.1001/jama.2019.4782.
10
The genetic architecture of Parkinson's disease.帕金森病的遗传结构。
Lancet Neurol. 2020 Feb;19(2):170-178. doi: 10.1016/S1474-4422(19)30287-X. Epub 2019 Sep 11.